Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors: the Japan Marrow Donor Program. - Wikidata - wikimedia - TriplyDB

Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors: the Japan Marrow Donor Program.

Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors: the Japan Marrow Donor Program.

http://www.wikidata.org/entity/Q52117021

about

How I treat acquired aplastic anemia Current concepts in the pathophysiology and treatment of aplastic anemia Milestones of Hematopoietic Stem Cell Transplantation - From First Human Studies to Current Developments Bone marrow transplantation versus immunosuppressive therapy in patients with acquired severe aplastic anemia.Unrelated donor stem cell transplantation in acquired severe aplastic anemia: a systematic review.Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA Working Party Aplastica anemia and viral hepatitis Outcome of unrelated donor stem cell transplantation for children with severe aplastic anemia Association between donor leukocyte telomere length and survival after unrelated allogeneic hematopoietic cell transplantation for severe aplastic anemia.Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysis Tacrolimus versus Cyclosporine after Hematopoietic Cell Transplantation for Acquired Aplastic Anemia.Haematopoietic stem cell transplantation to treat aplastic anaemia.Evaluation of HLA matching in unrelated hematopoietic stem cell transplantation for nonmalignant disorders.Aplastic anemia: pathophysiology and treatment.Evolving hematopoietic stem cell transplantation strategies in severe aplastic anemia.Favorable preliminary results using TLI/ATG-based immunomodulatory conditioning for matched unrelated donor allogeneic hematopoietic stem cell transplantation in pediatric severe aplastic anemia.An update on the management of severe idiopathic aplastic anaemia in children.Cyclophosphamide conditioning in patients with severe aplastic anaemia given unrelated marrow transplantation: a phase 1-2 dose de-escalation study Fludarabine-based conditioning for marrow transplantation from unrelated donors in severe aplastic anemia: early results of a cyclophosphamide dose deescalation study show life-threatening adverse events at predefined cyclophosphamide dose levels.Unrelated alternative donor transplantation for severe acquired aplastic anemia: a study from the French Society of Bone Marrow Transplantation and Cell Therapies and the EBMT Severe Aplastic Anemia Working Party.Long-term outcome of pediatric patients with severe aplastic anemia treated with antithymocyte globulin and cyclosporine.Immunosuppressive treatment in children with acquired aplastic anemia.Is it time for a change? The case for early application of unrelated allo-SCT for severe aplastic anemia.Lenograstim: a review of its use in chemotherapy-induced neutropenia, for acceleration of neutrophil recovery following haematopoietic stem cell transplantation and in peripheral blood stem cell mobilization.The Third Consensus Conference on the treatment of aplastic anemia.Treatment of refractory or relapsed acquired aplastic anemia: review of established and experimental approaches.Unrelated donor search and unrelated donor transplantation in the adult aplastic anaemia patient aged 18-40 years without an HLA-identical sibling and failing immunosuppression.Hematopoietic stem cell transplantation for aplastic anemia and paroxysmal nocturnal hemoglobinuria: current evidence and recommendations.Prophylactic and therapeutic treatment of graft-versus-host disease in Japan.Acquired aplastic anemia in Korean children: treatment guidelines from the Bone Marrow Failure Committee of the Korean Society of Pediatric Hematology Oncology.Updates on the pathophysiology and treatment of aplastic anemia: a comprehensive review.Effect of Recipient Age and Stem Cell Source on the Association between Donor Telomere Length and Survival after Allogeneic Unrelated Hematopoietic Cell Transplantation for Severe Aplastic Anemia.Transplantation of highly purified CD34+ progenitor cells from alternative donors in children with refractory severe aplastic anaemia.Non-radiotherapy conditioning with stem cell transplantation from alternative donors in children with refractory severe aplastic anemia.Unrelated cord blood transplantation in aplastic anemia: is anti-thymocyte globulin indispensable for conditioning?Second allogeneic hematopoietic stem cell transplantation in children with severe aplastic anemia.Correlation of rabbit antithymocyte globulin serum levels and clinical outcomes in children who received hematopoietic stem cell transplantation from an alternative donor.Unrelated donor bone marrow transplantation for children with severe aplastic anemia: minimal GVHD and durable engraftment with partial T cell depletion.Marrow transplants from matched unrelated donors for aplastic anaemia using alemtuzumab, fludarabine and cyclophosphamide based conditioning.Non-total body irradiation containing preparative regimen in alternative donor bone marrow transplantation for severe aplastic anemia.

P2860

Q24617687-69E61D0B-1CF5-4326-ACA1-524649492C6D Q24685812-8792701D-84DC-4F9E-BA76-78B17686C3F7 Q28067102-1E7A3623-7008-402E-A278-4451B814DD60 Q30249748-586B0C23-74DA-4A4A-BCC7-F0528C5AD7E1 Q33489272-6481838E-3FC0-42AB-9F14-498F37B86E49 Q33886206-FCB23C4F-02C0-4528-BA56-0BCECFBA8C7F Q34549277-601D4FDF-8065-4A34-B7C8-6F25A2868869 Q35190229-97D28C87-25C2-44B9-9FC4-27F80B602EFC Q35298077-9899E4E3-3590-4316-B2CB-C3F45C0CED3A Q35571068-C1B3E3C4-D166-46C8-B449-89A5C0BECDA8 Q36055158-A7652009-D745-4310-A858-8EB33859AC0D Q36150480-022D125D-12E5-4877-829E-0D815987EEC8 Q36305355-66CD2E93-D05E-4515-916A-4E9BDBA7B7DD Q36464602-EED0F7D4-F9FC-45CE-B51E-78FD0962407F Q36497220-2F5DD20B-A9F5-4E1F-B011-F18C829A730F Q36514033-AD740AB7-DA37-4F9E-8B45-C79CF06874F4 Q36703904-EA2363C1-8643-4119-8BBF-2737E08D72BD Q36884109-4A7E57F0-A689-49AD-B260-E1C1FD523717 Q36916440-C6F924D2-F2E6-4D1A-9D37-97A903E4466C Q37216480-CB013542-EFA9-476C-BF2A-A4976CD24785 Q37677193-7E032B35-6AC4-4956-A365-D05E0D89B1A5 Q37703129-C5537185-A784-4D6B-B70D-18D14B2FB175 Q37770210-DAF256E9-829E-45C7-8187-2B6F85B21DF8 Q37866758-314D2FB5-3336-47A2-AA46-CD95A5883819 Q37880645-65F43A81-EE6A-490A-92D1-1225F4CF63FD Q37884078-0601A297-1F58-478D-B679-CC53383904B5 Q38062303-560B90EC-3DB4-44EB-BD85-7B17828972A5 Q38261555-74F9859B-4015-4DA6-91DA-72034B28CF9C Q38416371-E66F9AEC-3A56-48B8-AE7A-D5E35431F5D1 Q38740791-43A8A299-5009-4E76-8678-50476DFF9815 Q39269167-4051C825-DE27-4E82-BBBA-E4F14B4145C1 Q39376504-5C587757-43A5-41B7-B6DE-592A689FDC86 Q39678480-82833B73-D397-4924-B8F8-055890559206 Q39705843-8BC4490C-3BEC-49BC-A27E-DC0C593DBA26 Q40104076-E13DD57D-C76F-4033-B55D-23E292325A9F Q40786744-C6FFAF39-C07A-4582-A577-DC7414842DF9 Q40929855-6E427B28-477F-4644-A3ED-EE79FA113F22 Q44707075-C4D0019B-8EFD-423B-80FF-AF3A4BE99C58 Q45235076-9B6B0560-6553-4199-B9ED-805703989D28 Q45286067-1D3F840F-0AE7-4717-9A43-D96B3040BDEA

P2860

Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors: the Japan Marrow Donor Program.

http://www.wikidata.org/entity/Q52117021

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Outcome of 154 patients with s ...... he Japan Marrow Donor Program.

@en

Outcome of 154 patients with s ...... he Japan Marrow Donor Program.

@nl

type

label

Outcome of 154 patients with s ...... he Japan Marrow Donor Program.

@en

Outcome of 154 patients with s ...... he Japan Marrow Donor Program.

@nl

prefLabel

Outcome of 154 patients with s ...... he Japan Marrow Donor Program.

@en

Outcome of 154 patients with s ...... he Japan Marrow Donor Program.

@nl

P1433

Q52117021-5D256CFF-498D-48A2-8B55-75776BF5F360

P1476

Q52117021-C8DA989D-CC57-442F-A439-467B40EFF99D

P2093

Q52117021-0DDD5F2A-56A9-4487-B9EF-5B007D960C8B

Q52117021-46C7980C-0486-4838-BBCD-61B7709BB0B3

Q52117021-52BEE06B-D5D4-4684-8630-CAA14CB3B28C

Q52117021-56AAF030-0E49-42A9-AC37-8BD8D3719B0E

Q52117021-66A50CC3-A1A4-4B70-BA1C-BEB2C82AC931

Q52117021-6715A079-20E7-4996-AF73-E6292C367621

Q52117021-77906BE5-C63A-434D-870B-15F0115C56A1

Q52117021-BC0FC0F2-470C-46BC-8A64-C532F95744FA

Q52117021-C1B22C7F-0C40-4DB3-8AE0-95CE6E7ED615

Q52117021-C4B02A12-25F2-4A3F-9A47-0F014FFC4D9A

P304

Q52117021-62060388-D2F7-485A-A446-A537662792B4

P31

Q52117021-C66BE49F-5762-42C9-9FF1-56923381FCEB

P356

Q52117021-F1B2B945-1197-49D5-8234-0561C7D7C15C

P407

Q52117021-1C8A438F-0587-4146-B445-D4B9785A5649

P433

Q52117021-CCDE6332-CA83-48FC-91AC-E05A5BD9421C

P478

Q52117021-CAFF9E2B-5EAE-4531-BC57-104670BDA61F

P577

Q52117021-64E65584-5438-44A2-9CA5-D3EAB9B34B5E

P698

Q52117021-BF929409-BBBF-4619-AF0F-80838EDE9561

P921

Q52117021-AB585DBE-E83A-4952-9D59-46F7280995C2

P356

BLOOD.V100.3.799

P1433

P1476

Outcome of 154 patients with s ...... he Japan Marrow Donor Program.

@en

P2093

Atsushi Kikuta

http://www.w3.org/2001/XMLSchema#string

Hisashi Sakamaki

http://www.w3.org/2001/XMLSchema#string

Hisato Kigasawa

http://www.w3.org/2001/XMLSchema#string

Koichiro Ikuta

http://www.w3.org/2001/XMLSchema#string

Masahiro Tsuchida

http://www.w3.org/2001/XMLSchema#string

Ryoji Kobayashi

http://www.w3.org/2001/XMLSchema#string

Seiji Kojima

http://www.w3.org/2001/XMLSchema#string

Shunichi Kato

http://www.w3.org/2001/XMLSchema#string

Takaharu Matsuyama

http://www.w3.org/2001/XMLSchema#string

Yasuo Morishima

http://www.w3.org/2001/XMLSchema#string

P304

799-803

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD.V100.3.799

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P577

2002-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12130489

http://www.w3.org/2001/XMLSchema#string

P921